Mark Dixon

18 days ago

Does Mark Dixon know more than me?

As discussed in bearcast earlier, shares in Skinbiotherapeutics (SBTX) may or may not be cheap or expensive. What I neglected to say is that some are arguing that the continued buying by Mark Dixon, he now owns 16.2%, shows that they are cheap: he would not buy so many shares if he did not know something. Hmmmm.

---